Recall events
/
Event 65585
Event summary
Timeline bucket June 20, 2013
Product types Food
Classifications Class I and Class II
Statuses Terminated
Recalling firm wording Beta Labs
Dossier provenance
Source snapshots represented here
openFDA Food Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
4 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
food · product 1 of 4
Oxyphen XR, 12 HR / CLINICAL STRENGTH FAT BURNER, 45 FAST ACTING EXTENDED RELEASE CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599747
F-2398-2014
Recall number F-2398-2014
Initiated June 20, 2013
Classification Class II
Status Terminated
Quantity 5951 units
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Code information Lot #s 200910 and 200911, Exp 10/16
Distribution pattern nationwide and UK
Official fact provenance
Dataset openFDA Food Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 ccbd901395e7f97453ba67323214b452ee901a828cb9048da8cb62e875bf39dc
Raw source locator 0001-food-enforcement-0001-of-0001.json.zip#results[14678]
FDA event record
· Exact recall-number query on openFDA
food · product 2 of 4
PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822
F-2399-2014
Recall number F-2399-2014
Initiated June 20, 2013
Classification Class I
Status Terminated
Quantity 2154 units
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Code information Lot # 58800512, Exp 05/16
Distribution pattern nationwide and UK
Official fact provenance
Dataset openFDA Food Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 ccbd901395e7f97453ba67323214b452ee901a828cb9048da8cb62e875bf39dc
Raw source locator 0001-food-enforcement-0001-of-0001.json.zip#results[14892]
FDA event record
· Exact recall-number query on openFDA
food · product 3 of 4
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
F-2400-2014
Recall number F-2400-2014
Initiated June 20, 2013
Classification Class II
Status Terminated
Quantity 743 units
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Code information Lot # 1205129, Exp 12/16
Distribution pattern nationwide and UK
Official fact provenance
Dataset openFDA Food Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 ccbd901395e7f97453ba67323214b452ee901a828cb9048da8cb62e875bf39dc
Raw source locator 0001-food-enforcement-0001-of-0001.json.zip#results[14811]
FDA event record
· Exact recall-number query on openFDA
food · product 4 of 4
RED VIPERS, ADVANCED FOCUS AND CONCENTRATION, HEIGHTENED ENERGY LEVELS, 75mg EPHEDRA, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559819
F-2401-2014
Recall number F-2401-2014
Initiated June 20, 2013
Classification Class II
Status Terminated
Quantity 743 units
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Code information Lot # 1205128 (90ct Bottle) Expires 12/16
Distribution pattern nationwide and UK
Official fact provenance
Dataset openFDA Food Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 ccbd901395e7f97453ba67323214b452ee901a828cb9048da8cb62e875bf39dc
Raw source locator 0001-food-enforcement-0001-of-0001.json.zip#results[14825]
FDA event record
· Exact recall-number query on openFDA
